Here, we report that the COX4 isoforms differentially modulate the metabolic profile of glioma cells, in particular, the concentration of metabolites involved in glycolysis, fatty acid metabolism, purine metabolism, and glutathione metabolism. This evidence concerns the gene COX4I2 and central nervous system cancer.